THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Reduce hands-on time from days to minutes with Devyser’s easy-to-use NGS library prep kit for complete characterization of genes involved in familial hypercholesterolemia.
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Biocartis is pleased to launch a new breast cancer portfolio: Idylla™ PIK3CA-AKT1 Mutation Assay, APIS Breast Cancer Subtyping Kit and APIS ESR1 Mutations Kit.
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
We are pleased to share the ZytoVision product catalogue for 2023/2024.
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Benefit from proven, highly sensitive technology to conduct accurate non-invasive screening for fetal RHD that helps clinicians avoid untargeted and unnecessary treatment.
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Among the studies published, four studies on the Idylla™ GeneFusion Assay highlighted the strengths of Idylla™ testing including high accuracy, ease-of-use and rapid time-to-results.
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Use Zytovision FISH probes to detect gene fusion status in NTRK1/2/3 genes.
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
With the AmplideX Trio, you can use one shared workflow to analyze CFTR, SMN1/2, and FMR1. This saves your lab tech time, simplifies training, and reduces consumables used.
Products are for professional/laboratory use only
The Idylla IDH1-2 Mutation Assay Kit (RUO)1 can detect five mutations in the IDH1 gene and 10 mutations in the IDH2 gene, along with an integrated processing control. The turnaround time is approximately 95 minutes from sample to result. The assay performance has been evaluated at multiple sites in both the US and Europe.
Products are for professional/laboratory use only
Within 180 minutes and with less than 2 minutes hands-on time, the fully automated Idylla™ GeneFusion cartridge detects ALK, ROS1 and RET fusions & MET exon 14 skipping in a single cartridge using only 1-3* FFPE tissue sections from patients with NSCLC.